Table 4.
28 Lung Cancer Patients * | 20 Cancer-Free Individuals | |
---|---|---|
Median age, years (min, max) | 65 (37, 79) | 66 (36, 79) |
Sex, n (%) | ||
Male | 7 (25%) | 5 (25%) |
Female | 21 (75%) | 15 (75%) |
Race, n (%) | ||
White | 20 (71.4%) | 14 (70.0%) |
Black | 3 (10.7%) | 2 (10.0%) |
Asia | 5 (17.9%) | 4 (20.0%) |
Smoking status | ||
Yes | 12 | 8 |
No | 13 | 9 |
Unknown | 3 | 2 |
Histology | Adenocarcinoma. | |
TNM Stage I | ||
III | 5 (17.9) | |
IV | 23 (82.1) |
* Of the lung cancer patients, four had proven targetable EGFR mutations in their tumor tissues.